Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: A novel therapeutic strategy

Molecular Therapy

Volumn 21, Issue 1, 2013, Pages 57-67

  Ray, Upasana ^a   Roy, Chaitrali L ^a   Kumar, Anuj ^a   Mani, Prashant ^b   Joseph, Agnel P ^a   Sudha, G ^a   Sarkar, Debi P ^b   Srinivasan, N ^a   Das, Saumitra ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LA ANTIGEN; NONSTRUCTURAL PROTEIN 3; SERINE; VIROSOME; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; ENCAPSULATION; ENZYME BINDING; GENOTYPE; HEPATITIS; IN VIVO STUDY; INHIBITION KINETICS; INTERNAL RIBOSOME ENTRY SITE; MALE; MOUSE; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; SEQUENCE ALIGNMENT; TRANSLATION REGULATION; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS REPLICATION; WESTERN BLOTTING;

HEPATITIS C VIRUS; SENDAI VIRUS;

EID: 84871920117     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.151     Document Type: Article

References (34)

1. Choo, QL, Kuo, G, Weiner, AJ, Overby, LR, Bradley, DW and Houghton, M (1989).Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitisgenome. Science 244: 359-362. (Pubitemid 19117877)
2. Kato, T, Date, T, Miyamoto, M, Sugiyama, M, Tanaka, Y, Orito, E et al. (2005).Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitivereplicon system. J Clin Microbiol 43: 5679-5684. (Pubitemid 41612348)
3. Houghton, M, Weiner, A, Han, J, Kuo, G and Choo, QL (1991). Molecular biology ofthe hepatitis C viruses: implications for diagnosis, development and control of viraldisease. Hepatology 14: 381-388.
4. Saito, I, Miyamura, T, Ohbayashi, A, Harada, H, Katayama, T, Kikuchi, S et al. (1990).Hepatitis C virus infection is associated with the development of hepatocellularcarcinoma. Proc Natl Acad Sci USA 87: 6547-6549.
5. Tsukiyama-Kohara, K, Iizuka, N, Kohara, M and Nomoto, A (1992). Internal ribosomeentry site within hepatitis C virus RNA. J Virol 66: 1476-1483.
6. Wang, C, Sarnow, P and Siddiqui, A (1993). Translation of human hepatitis C virusRNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol67: 3338-3344. (Pubitemid 23143708)
7. Reynolds, JE, Kaminski, A, Carroll, AR, Clarke, BE, Rowlands, DJ and Jackson, RJ (1996).Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is atthe authentic initiation codon. RNA 2: 867-878. (Pubitemid 26374198)
8. Lu, HH and Wimmer, E (1996). Poliovirus chimeras replicating under the translationalcontrol of genetic elements of hepatitis C virus reveal unusual properties of theinternal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci USA 93: 1412-1417. (Pubitemid 26075136)
9. Kamoshita, N, Tsukiyama-Kohara, K, Kohara, M and Nomoto, A (1997). Geneticanalysis of internal ribosomal entry site on hepatitis C virus RNA: implication forinvolvement of the highly ordered structure and cell type-specific transacting factors.Virology 233: 9-18. (Pubitemid 27348764)
10. Ray, U and Das, S (2011). Interplay between NS3 protease and human La proteinregulates translation-replication switch of Hepatitis C virus. Sci Rep 1: 1.
11. Bartenschlager, R and Sparacio, S (2007). Hepatitis C virus molecular clones and theirreplication capacity in vivo and in cell culture. Virus Res 127: 195-207. (Pubitemid 47058197)
12. Pawlotsky, JM, Germanidis, G, Frainais, PO, Bouvier, M, Soulier, A, Pellerin, M et al.(1999). Evolution of the hepatitis C virus second envelope protein hypervariableregion in chronically infected patients receiving alpha interferon therapy. J Virol 73:6490-6499. (Pubitemid 29327829)
13. Manns, MP, McHutchison, JG, Gordon, SC, Rustgi, VK, Shiffman, M, Reindollar, R etal. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958-965. (Pubitemid 32913521)
14. Yoshida, EM, Sherman, M, Bain, VG, Cooper, CL, Deschênes, M, Marotta, PJ etal.; Pegasys Study Group. (2009). Re-treatment with peginterferon alfa-2a andribavirin in patients with chronic hepatitis C who have relapsed or not respondedto a first course of pegylated interferon-based therapy. Can J Gastroenterol 23:180-184.
15. Toniutto, P, Fabris, C, Bitetto, D, Fornasiere, E, Rapetti, R and Pirisi, M (2007).Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus. CurrOpin Investig Drugs 8: 150-158. (Pubitemid 46438469)
16. Mondal, T, Ray, U, Manna, AK, Gupta, R, Roy, S and Das, S (2008). Structuraldeterminant of human La protein critical for internal initiation of translation ofhepatitis C virus RNA. J Virol 82: 11927-11938.
17. Dasgupta, A, Das, S, Izumi, R, Venkatesan, A and Barat, B (2004). Targeting internalribosome entry site (IRES)-mediated translation to block hepatitis C and other RNAviruses. FEMS Microbiol Lett 234: 189-199. (Pubitemid 38595632)
18. Pawlotsky, JM, Chevaliez, S and McHutchison, JG (2007). The hepatitis Cvirus life cycle as a target for new antiviral therapies. Gastroenterology 132:1979-1998. (Pubitemid 46695724)
19. Roy, S, Gupta, N, Subramanian, N, Mondal, T, Banerjea, AC and Das, S (2008).Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viralRNA translation and replication. J Gen Virol 89(Pt 7): 1579-1586.
20. Subramanian, N, Mani, P, Roy, S, Gnanasundram, SV, Sarkar, DP and Das, S (2009).Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver usingSendai virosomes. J Gen Virol 90(Pt 8): 1812-1819.
21. Pawlotsky, JM (2003). Hepatitis C virus genetic variability: pathogenic and clinicalimplications. Clin Liver Dis 7: 45-66.
22. Pudi, R, Srinivasan, P and Das, S (2004). La protein binding at the GCAC site nearthe initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNAto influence internal ribosome entry site-mediated translation. J Biol Chem 279:29879-29888. (Pubitemid 38937906)
23. Bagai, S, Puri, A, Blumenthal, R and Sarkar, DP (1993). Hemagglutinin-neuraminidaseenhances F protein-mediated membrane fusion of reconstituted Sendai virusenvelopes with cells. J Virol 67: 3312-3318. (Pubitemid 23143704)
24. Nijhara, R, Jana, SS, Goswami, SK, Rana, A, Majumdar, SS, Kumar, V et al. (2001).Sustained activation of mitogen-activated protein kinases and activator protein 1 bythe hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol 75: 10348-10358. (Pubitemid 32948065)
25. Ramani, K, Hassan, Q, Venkaiah, B, Hasnain, SE and Sarkar, DP (1998). Site-specificgene delivery in vivo through engineered Sendai viral envelopes. Proc Natl Acad SciUSA 95: 11886-11890. (Pubitemid 28460509)
26. Ali, N, Pruijn, GJ, Kenan, DJ, Keene, JD and Siddiqui, A (2000). Human La antigen isrequired for the hepatitis C virus internal ribosome entry site-mediated translation.J Biol Chem 275: 27531-27540.
27. Martino, L, Pennell, S, Kelly, G, Bui, TT, Kotik-Kogan, O, Smerdon, SJ et al. (2012).Analysis of the interaction with the hepatitis C virus mRNA reveals an alternativemode of RNA recognition by the human La protein. Nucleic Acids Res 40:1381-1394.
28. Terribilini, M, Lee, JH, Yan, C, Jernigan, RL, Honavar, V and Dobbs, D (2006). Predictionof RNA binding sites in proteins from amino acid sequence. RNA 12: 1450-1462. (Pubitemid 44141524)
29. Kumar, M, Gromiha, MM and Raghava, GP (2008). Prediction of RNA binding sites ina protein using SVM and PSSM profile. Proteins 71: 189-194. (Pubitemid 351358602)
30. Thompson, JD, Higgins, DG and Gibson, TJ (1994). CLUSTAL W: improving thesensitivity of progressive multiple sequence alignment through sequence weighting,position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680. (Pubitemid 24354800)
31. Gilson, MK and Honig, B (1988). Calculation of the total electrostatic energy of amacromolecular system: solvation energies, binding energies, and conformationalanalysis. Proteins 4: 7-18.
32. Duhovny, D, Nussinov, R and Wolfson, HJ (2002). Efficient unbound docking of rigidmolecules. In Gusfield et al. (ed.) Proceedings of the 2'nd Workshop on Algorithms inBioinformatics (WABI). Lecture Notes in Computer Science: Italy, Rome, 2452, pp185-200.
33. Michael, F, Kerstin, B, Artur, K, Volker, L, Verena, S and Bartenschalger, R (2003).Hepatitis C virus RNA replication is resistant to tumour necrosis factor. J Gen Virol84: 1253-1259.
34. Wakita, T, Pietschmann, T, Kato, T, Date, T, Miyamoto, M, Zhao, Z et al. (2005).Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.Nat Med 11: 791-796. (Pubitemid 41021213)